Forefront Analytics’s Verona Pharma VRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,446
2022
Q3
$138K Sell
13,446
-13,750
2022
Q2
$112K Sell
27,196
-8,460
2022
Q1
$179K Buy
35,656
+1,550
2021
Q4
$229K Buy
34,106
+950
2021
Q3
$181K Buy
33,156
+17,650
2021
Q2
$104K Buy
15,506
+1,404
2021
Q1
$118K Buy
+14,102